Invesco’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $259M | Buy |
4,012,494
+364,431
| +10% | +$25.7M | 0.03% | 601 |
|
|
2025
Q4 | $246M | Buy |
3,648,063
+402,293
| +12% | +$27.1M | 0.02% | 599 |
|
|
2025
Q3 | $238M | Sell |
3,245,770
-220,119
| -6% | -$14.6M | 0.04% | 594 |
|
|
2025
Q2 | $180M | Sell |
3,465,889
-428,408
| -11% | -$24.4M | 0.03% | 674 |
|
|
2025
Q1 | $248M | Buy |
3,894,297
+1,519,875
| +64% | +$88.3M | 0.05% | 514 |
|
|
2024
Q4 | $114M | Buy |
2,374,422
+462,762
| +24% | +$23.7M | 0.02% | 778 |
|
|
2024
Q3 | $109M | Sell |
1,911,660
-312,278
| -14% | -$17.9M | 0.02% | 772 |
|
|
2024
Q2 | $116M | Buy |
2,223,938
+135,528
| +6% | +$5.94M | 0.02% | 732 |
|
|
2024
Q1 | $85M | Buy |
2,088,410
+57,776
| +3% | +$2.17M | 0.02% | 831 |
|
|
2023
Q4 | $75.1M | Buy |
2,030,634
+13,612
| +0.7% | +$513K | 0.02% | 844 |
|
|
2023
Q3 | $77.1M | Sell |
2,017,022
-459,123
| -19% | -$18.8M | 0.02% | 805 |
|
|
2023
Q2 | $89.3M | Sell |
2,476,145
-1,015,032
| -29% | -$34.6M | 0.02% | 755 |
|
|
2023
Q1 | $133M | Sell |
3,491,177
-2,514,274
| -42% | -$118M | 0.04% | 605 |
|
|
2022
Q4 | $342M | Buy |
6,005,451
+366,954
| +7% | +$18.8M | 0.1% | 275 |
|
|
2022
Q3 | $223M | Buy |
5,638,497
+67,802
| +1% | +$3M | 0.07% | 377 |
|
|
2022
Q2 | $245M | Buy |
5,570,695
+249,572
| +5% | +$10.8M | 0.07% | 362 |
|
|
2022
Q1 | $212M | Sell |
5,321,123
-185,110
| -3% | -$6.59M | 0.05% | 472 |
|
|
2021
Q4 | $221M | Buy |
5,506,233
+176,888
| +3% | +$6.6M | 0.05% | 482 |
|
|
2021
Q3 | $217M | Sell |
5,329,345
-322,277
| -6% | -$13.5M | 0.05% | 459 |
|
|
2021
Q2 | $257M | Buy |
5,651,622
+129,888
| +2% | +$5.75M | 0.06% | 395 |
|
|
2021
Q1 | $230M | Buy |
5,521,734
+189,126
| +4% | +$8.63M | 0.06% | 408 |
|
|
2020
Q4 | $228M | Buy |
5,332,608
+1,086,911
| +26% | +$39.1M | 0.07% | 376 |
|
|
2020
Q3 | $112M | Buy |
4,245,697
+563,416
| +15% | +$15.7M | 0.04% | 597 |
|
|
2020
Q2 | $98.7M | Buy |
3,682,281
+4,349
| +0.1% | +$98.1K | 0.04% | 596 |
|
|
2020
Q1 | $66.2M | Sell |
3,677,932
-1,050,885
| -22% | -$19.9M | 0.03% | 671 |
|
|
2019
Q4 | $83.8M | Sell |
4,728,817
-537,977
| -10% | -$9.32M | 0.03% | 750 |
|
|
2019
Q3 | $81.7M | Sell |
5,266,794
-120,615
| -2% | -$1.99M | 0.02% | 745 |
|
|
2019
Q2 | $92.6M | Buy |
5,387,409
+1,183,551
| +28% | +$19.1M | 0.02% | 719 |
|
|
2019
Q1 | $67.7M | Sell |
4,203,858
-10,256
| -0.2% | -$166K | 0.02% | 695 |
|
|
2018
Q4 | $61.7M | Buy |
4,214,114
+34,661
| +0.8% | +$553K | 0.02% | 662 |
|
|
2018
Q3 | $75.9M | Buy |
4,179,453
+113,537
| +3% | +$1.99M | 0.02% | 674 |
|
|
2018
Q2 | $68.6M | Sell |
4,065,916
-161,566
| -4% | -$3.05M | 0.02% | 701 |
|
|
2018
Q1 | $82.8M | Sell |
4,227,482
-13,130
| -0.3% | -$254K | 0.03% | 541 |
|
|
2017
Q4 | $85.9M | Sell |
4,240,612
-185,614
| -4% | -$3.41M | 0.03% | 552 |
|
|
2017
Q3 | $76.9M | Sell |
4,426,226
-16,074
| -0.4% | -$218K | 0.03% | 596 |
|
|
2017
Q2 | $57M | Sell |
4,442,300
-42,311
| -0.9% | -$565K | 0.02% | 716 |
|
|
2017
Q1 | $58.1M | Buy |
4,484,611
+2,146,872
| +92% | +$27.1M | 0.02% | 711 |
|
|
2016
Q4 | $23.1M | Buy |
2,337,739
+526,835
| +29% | +$5.77M | 0.01% | 1100 |
|
|
2016
Q3 | $21.9M | Buy |
1,810,904
+17,370
| +1% | +$178K | 0.01% | 1117 |
|
|
2016
Q2 | $15.5M | Sell |
1,793,534
-929,929
| -34% | -$9.18M | 0.01% | 1246 |
|
|
2016
Q1 | $25.8M | Buy |
2,723,463
+331,990
| +14% | +$3.12M | 0.01% | 1027 |
|
|
2015
Q4 | $41.4M | Sell |
2,391,473
-70,363
| -3% | -$1.12M | 0.02% | 845 |
|
|
2015
Q3 | $33.1M | Buy |
2,461,836
+1,359,560
| +123% | +$27.3M | 0.01% | 930 |
|
|
2015
Q2 | $24.9M | Buy |
+1,102,276
| New | +$19.4M | 0.01% | 1118 |
|
|
2014
Q1 | – | Sell |
-6,040
| Closed | -$91K | – | 4149 |
|
|
2013
Q4 | $91K | Buy |
+6,040
| New | +$77.7K | ﹤0.01% | 4036 |
|
Other funds holding HALO
VCM
VPM
SCM
Invesco's HALO Position: Q1 2026 in Review
Invesco increased its Halozyme (HALO) stake by 10% in Q1 2026, buying an estimated $25.7M and bringing the position to 4,012,494 shares worth $259M. The position accounts for 0.03% of the portfolio, ranked #601.
Invesco first reported a position in HALO in Q4 2013 and has held it in 45 quarters since. The position peaked at $342M in Q4 2022. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.
- Invesco held 4,012,494 shares of Halozyme worth $259M as of Q1 2026.
- Invesco bought 364,431 Halozyme shares in Q1 2026, an estimated $25.7M.
- Halozyme made up 0.03% of Invesco's portfolio in Q1 2026, its #601 holding.
- Invesco first reported a position in Halozyme in Q4 2013 and has held it in 45 quarters since.
- Invesco's Halozyme position peaked at $342M in Q4 2022.
- 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.
Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.